Antihypertensives prevent CVD even when BP normal
Antihypertensives can prevent serious cardiovascular disease (CVD) even among adults with normal blood pressure, new research suggests.
Antihypertensives’ benefits emerged, regardless of baseline blood pressure, in people who previously had a myocardial infarction or stroke, and in those who never developed CVD.
Researchers pooled data from 344,716 adults (average age 65 years) in 48 randomised trials. Of these, 186,988 had not been diagnosed with CVD. Of those with and without a history of CVD, 19.8 and 8.0 per cent respectively had normal or high-normal systolic blood pressure (less than 130mmHg) at baseline. Clinical guidelines typically limit antihypertensives to people with blood pressure above 140/90mmHg.
During a median follow-up of 4.15 years, 12.3 per cent of participants experienced at least one major cardiovascular event, including ischaemic heart disease (5.6 per cent), stroke (4.0 per cent), CV death (3.4 per cent) and heart failure (2.4 per cent). Overall mortality was 8.4 per cent. Each 5mmHg fall in systolic blood pressure reduced the risk of stroke and heart failure by about 13 per cent, major CVD by about 10 per cent, ischaemic heart disease by 8 per cent and cardiovascular death by 5 per cent.
The study suggests that “a fixed degree of pharmacological blood pressure lowering is similarly effective for primary and secondary prevention of major cardiovascular disease, even at blood pressure levels currently not considered for treatment”.
The study did not, however, assess other outcomes that antihypertensives may partially prevent, such as valvular heart disease, peripheral vascular disease, atrial fibrillation or diabetes, or potential harms.
“This new evidence tells us that decisions to prescribe blood pressure medication should not be based simply on a prior diagnosis of cardiovascular disease or an individual’s blood pressure level,” says lead author Professor Kazem Rahimi from the University of Oxford.
“Instead, medication should be viewed as an effective tool for preventing cardiovascular disease in people at increased risk of developing heart disease or stroke. Clinical guidelines should be changed to reflect these findings.”
This video offers advice and inspiration from pharmacist Ade Williams that you can use to improve your men’s health offering
Discover the key benefits of different types of laxatives, and the right questions to ask customers to ensure you know which to recommend
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Hancock: ‘We will unleash the potential of our pharmacies’
Matt Hancock: "We will unleash the potential of our pharmacies because there really is so much more they are capable of doing."
1 Min Article
New antibody study will inform Govt lockdown strategy
A new Government-funded study is using Covid-19 antibody testing to determine how widespread coronavirus is in the community in Britain.
1 Min Article
Covid-19 and mental health
Viatris has created this short video based on a publication reviewing global research into the potential impact of the Covid-19 pandemic on mental health. It identifies six areas where psychiatrists can play a role in supporting people's mental health through these difficult times.
4 Min Module
Treating acid reflux and heartburn in the pharmacy
Understand how omeprazole 20mg works to treat heartburn and acid reflux symptoms
2 Min Module
Build your confidence in advising customers with erection problems so you can help make a real difference to their lives
2 Min Module
Managing heartburn and indigestion in the pharmacy
Learn how to identify and help customers manage heartburn and indigestion, from recommending the right products to ease symptoms, to self-care advice and identifying red flags for referral
10 Min Module